Search

everythinglearnresearchcommunity

for

Search:↓

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

Rats had lasting erectile problems after stopping a certain medication.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Combining α1A-blockers with Prozac is more effective for treating premature ejaculation than Prozac alone.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.